Ra Medical Systems, Inc. (RMED) |
| 0.594 0.054 (10%) 08-17 16:00 |
| Open: | 0.55 |
| High: | 0.594 |
| Low: | 0.52 |
| Volume: | 74,500 |
| Market Cap: | 4(M) |
| PE Ratio: | -0.02 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Medical - Devices |
| Sector: | Healthcare |
| Technical analysis | ||||
| sell | buy | |||
| Resistance 2: | |
| Resistance 1: | |
| Pivot price: | |
| Support 1: | |
| Support 2: | |
| 52w High: | 11.135 |
| 52w Low: | 0.4808 |
Ra Medical Systems, Inc. operates as a medical technology enterprise specializing in the creation, production, and sale of excimer lasers. These lasers are specifically designed for the management of vascular conditions linked to immune-mediated inflammation. Among its key offerings is the DABRA system, a minimally invasive solution that utilizes an excimer laser and a disposable catheter. This innovative technology enables physicians to perform endovascular treatments, effectively clearing arteriosclerotic blockages in the lower extremities, which are often a result of lower extremity vascular disease, through laser radiation ablation. The company primarily channels its products to the U.S. market through a network of distributors. Founded in 2002, Ra Medical Systems' corporate base is located in Carlsbad, California.
| EPS | |
| Book Value | |
| PEG Ratio | |
| Gross Profit |
| Profit Margin (%) | |
| Operating Margin (%) | |
| Return on Assets (ttm) | |
| Return on Equity (ttm) |
Mon, 22 Dec 2025
Vagus nerve-mediated neuroimmune modulation for rheumatoid arthritis: a pivotal randomized controlled trial - Nature
Fri, 18 Apr 2025
Association between plausible genetic factors and weight loss from GLP1-RA and bariatric surgery - Nature
Mon, 31 Jul 2023
Ra Medical Systems Announces Proposed Name and Ticker Symbol Changes - Yahoo Finance
Wed, 05 Jul 2023
Ra Medical announces international distribution expansion - MassDevice
Tue, 27 Sep 2022
Catheter Precision Names Fatih Ayoglu as Business Development Manager—EMEA - citybiz
Tue, 13 Sep 2022
Catheter Precision agrees to reverse merger, securing cash to target cardiac electrophysiology market - MedTech Dive
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |